Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties
暂无分享,去创建一个
[1] R. Hovorka,et al. Coming of age: the artificial pancreas for type 1 diabetes , 2016, Diabetologia.
[2] Claudio Cobelli,et al. Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results , 2018, IEEE Transactions on Biomedical Engineering.
[3] Eyal Dassau,et al. Zone Model Predictive Control: A Strategy to Minimize Hyper- and Hypoglycemic Events , 2010, Journal of diabetes science and technology.
[4] Dawei Shi,et al. Zone Model Predictive Control with Glucose- and Velocity-Dependent Control Penalty Adaptation for an Artificial Pancreas , 2018, 2018 Annual American Control Conference (ACC).
[5] Eyal Dassau,et al. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control‐based fully‐automated artificial pancreas in patients with type 1 diabetes: a pilot study , 2017, Diabetes, obesity & metabolism.
[6] Eyal Dassau,et al. Closed-Loop Control of Artificial Pancreatic $\beta$ -Cell in Type 1 Diabetes Mellitus Using Model Predictive Iterative Learning Control , 2010, IEEE Transactions on Biomedical Engineering.
[7] Irl B. Hirsch,et al. Multivariable adaptive identification and control for artificial pancreas systems , 2015 .
[8] Eyal Dassau,et al. Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial. , 2015, The Journal of clinical endocrinology and metabolism.
[9] B. Buckingham,et al. Closed-loop control in type 1 diabetes. , 2016, The lancet. Diabetes & endocrinology.
[10] Eyal Dassau,et al. Periodic-Zone Model Predictive Control for Diurnal Closed-Loop Operation of an Artificial Pancreas , 2013, Journal of diabetes science and technology.
[11] Eyal Dassau,et al. Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control. , 2017, Diabetes technology & therapeutics.
[12] Eyal Dassau,et al. An Enhanced Model Predictive Control for the Artificial Pancreas Using a Confidence Index Based on Residual Analysis of Past Predictions , 2017, Journal of diabetes science and technology.
[13] Robert A. Vigersky,et al. Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes , 2016, Diabetologia.
[14] R. Hovorka,et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.
[15] Eyal Dassau,et al. Switched LPV Glucose Control in Type 1 Diabetes , 2016, IEEE Transactions on Biomedical Engineering.
[16] Lauren M. Huyett,et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms , 2014, Diabetes Care.
[17] Howard C. Zisser,et al. Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report , 2016, Diabetes Care.
[18] Francis J. Doyle,et al. A run‐to‐run framework for prandial insulin dosing: handling real‐life uncertainty , 2007 .
[19] Howard Zisser,et al. Glucose Estimation and Prediction through Meal Responses Using Ambulatory Subject Data for Advisory Mode Model Predictive Control , 2007, Journal of diabetes science and technology.
[20] Ali Cinar,et al. Adaptive control of artificial pancreas systems - a review. , 2014, Journal of healthcare engineering.
[21] Dale E. Seborg,et al. Control-Relevant Models for Glucose Control Using A Priori Patient Characteristics , 2012, IEEE Transactions on Biomedical Engineering.
[22] C. C. Palerm,et al. A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes. , 2008, Journal of process control.
[23] B. Wayne Bequette,et al. Extended multiple model prediction with application to blood glucose regulation , 2012 .
[24] Ahmad Haidar,et al. The Artificial Pancreas: How Closed-Loop Control Is Revolutionizing Diabetes , 2016, IEEE Control Systems.
[25] Eyal Dassau,et al. Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes , 2016, Autom..
[26] Eyal Dassau,et al. Dynamic Insulin on Board: Incorporation of Circadian Insulin Sensitivity Variation , 2013, Journal of diabetes science and technology.
[27] Eyal Dassau,et al. Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia , 2017, Diabetes Care.
[28] C. Cobelli,et al. The UVA/PADOVA Type 1 Diabetes Simulator , 2014, Journal of diabetes science and technology.
[29] F. El-Khatib,et al. Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Dual Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine , 2007, Journal of diabetes science and technology.
[30] Eyal Dassau,et al. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial , 2017, Diabetes Care.
[31] Eyal Dassau,et al. Multi-Zone-MPC: Clinical Inspired Control Algorithm for the Artificial Pancreas , 2011 .
[32] Eyal Dassau,et al. Event-Triggered Model Predictive Control for Embedded Artificial Pancreas Systems , 2018, IEEE Transactions on Biomedical Engineering.
[33] Eyal Dassau,et al. Enhanced Model Predictive Control (eMPC) Strategy for Automated Glucose Control. , 2016, Industrial & engineering chemistry research.
[34] Eyal Dassau,et al. Velocity-weighting & velocity-penalty MPC of an artificial pancreas: Improved safety & performance , 2018, Autom..
[35] Stephen P. Boyd,et al. Dynamic energy management with scenario-based robust MPC , 2017, 2017 American Control Conference (ACC).
[36] Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2016, Diabetes Care.